CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc.
(OTCEM:CTHZ)
$0.0001
0[0.00%]
At close: Jul 19

CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. Stock (OTC:CTHZ), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Analyst Ratings for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc.

No data available to display
date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

FAQ

Q

What is the target price for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. (CTHZ)?

A

There is no price target for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc..

Q

What is the most recent analyst rating for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. (CTHZ)?

A

There is no analyst for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc..

Q

When was the last upgrade for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. (CTHZ)?

A

There is no last upgrade for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc..

Q

When was the last downgrade for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. (CTHZ)?

A

There is no last downgrade for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc..

Q

When is the next analyst rating going to be posted or updated for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. (CTHZ)?

A

There is no next analyst rating for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc..

Q

Is the Analyst Rating CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc. (CTHZ) correct?

A

There is no next analyst rating for CANCER TREATMNT HLDGS INC by Cancer Treatment Holdings, Inc..

Browse analyst ratings and price targets on all stocks.